Chin-Sheng Hung became Chief Medical Officer of SL Science Holding Limited on November 1, 2026, per the SEC Form 3 filed November 6, 2026. A Form 3 is the first ownership report a new officer files, due within 10 days of taking the role.
Who to call at SL Science Holding Limited, and when
A new leader at SL Science Holding Limited brings new priorities and often new vendors. The first weeks are when they listen.
An alert the day SL Science Holding Limited raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at SL Science Holding Limited, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at SL Science Holding Limited. With Fundz connected, it knows.
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
SL Science Holding Limited
Location
Cayman Islands
About
SL Science Holding Limited is a holding company formed following the merger of SL BIO Ltd. and Horizon Space Acquisition II Corp. It focuses on advancing innovative oncology therapies. The company seeks to standardize and scale cell-based therapies for cancer treatment. SL Science aims to utilize capital markets for clinical and commercial growth.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment SL Science Holding Limited changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Cayman IslandsBiotechnologyHealth CareTherapeutics